|
Volumn 87, Issue 10, 2000, Pages 697-701
|
Flavopiridol, a cyclin-dependent kinase inhibitor;Le flavopiridol, une proteine kinase dependante des cyclines
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
FLAVOPIRIDOL;
PACLITAXEL;
ANTINEOPLASTIC AGENT;
CYCLIN DEPENDENT KINASE;
FLAVONOID;
PIPERIDINE DERIVATIVE;
CANCER CHEMOTHERAPY;
CELL CYCLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG STRUCTURE;
DRUG UTILIZATION;
ENZYME INHIBITION;
HUMAN;
MAXIMUM PERMISSIBLE DOSE;
NEUTROPENIA;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PROSTATE CANCER;
PROTEIN EXPRESSION;
REVIEW;
STRUCTURE ANALYSIS;
TUMOR REGRESSION;
APOPTOSIS;
CELL CULTURE;
CELL DIVISION;
CHEMISTRY;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG RESISTANCE;
DRUG SCREENING;
MULTIDRUG RESISTANCE;
NEOPLASM;
STRUCTURE ACTIVITY RELATION;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL DIVISION;
CLINICAL TRIALS;
CYCLIN-DEPENDENT KINASES;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
DRUG SCREENING ASSAYS, ANTITUMOR;
FLAVONOIDS;
HUMANS;
NEOPLASMS;
PIPERIDINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUMOR CELLS, CULTURED;
|
EID: 0033724646
PISSN: 00074551
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (47)
|